Sindlev Rene 4
4 · Enochian Biosciences Inc · Filed Jul 18, 2022
Insider Transaction Report
Form 4
Sindlev Rene
Director10% Owner
Transactions
- Other
Common Stock
2022-06-08−125,000→ 0 total(indirect: By RS Arving ApS) - Other
Common Stock
2022-06-08−128,493→ 0 total(indirect: By RS Group ApS)
Holdings
- 9,668,351(indirect: By RS Bio ApS)
Common Stock
Footnotes (2)
- [F1]On May 18, 2022, the reporting person entered into a contract to purchase shares in a private transaction. Certain conditions of the transaction were never fulfilled, including delivery of the shares, and on June 8, 2022, the reporting person terminated that contract, resulting in a return to the reporting person of the cash paid.
- [F2]On May 18, 2022, the reporting person entered into a contract to accept shares of the Issuer to satisfy a debt owed to the reporting person. The shares were never delivered to the reporting person and as a result on June 8, 2022 the reporting person terminated the contract.